Jump to content

Health Service Medical Supplies (Costs) Act 2017

From Wikipedia, the free encyclopedia

Health Service Medical Supplies (Costs) Act 2017
Act of Parliament
Long titleAn Act to make provision in connection with controlling the cost of health service medicines and other medical supplies; to make provision in connection with the provision of pricing and other information by those manufacturing, distributing or supplying those medicines and supplies, and other related products, and the disclosure of that information; and for connected purposes.
Citation2017 c. 23
Introduced byJeremy Hunt (Commons)
Lord O’Shaughnessy (Lords)
Territorial extent England and Wales, Scotland and Northern Ireland
Dates
Royal assent27 April 2017
History of passage through Parliament
Text of statute as originally enacted
Revised text of statute as amended

The Health Service Medical Supplies (Costs) Act 2017 (c. 23) is an Act of the Parliament of the United Kingdom.

It provides that pharmaceutical companies can be compelled to reduce the price of a generic medicine or introduce other controls on branded products in cases where charges are “unreasonable”.[1]

References

[edit]
  1. ^ "New legislation passed to prevent excessive price hiking of generic drugs". Pharmaceutical Journal. 3 May 2017. Retrieved 30 May 2017.
[edit]